MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
OD | 4 | 27 | 1 | 2 | 1 | 2 | 37 | ||
OG | 10 | 23 | 1 | 2 | 1 | 0 | 37 | ||
OD + OG | 14 | 50 | 2 | 4 | 2 | 2 | 74 | ||
N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
OD | 10,81% | 72,97% | 2,70% | 5,41% | 2,70% | 5,41% | 100,00% | ||
OG | 27,03% | 62,16% | 2,70% | 5,41% | 2,70% | 0,00% | 100,00% | ||
MOYENNE | 18,92% | 67,57% | 2,70% | 5,41% | 2,70% | 2,70% | 100,00% | ||
NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
HOMMES | 4 | 16 | 1 | 0 | 2 | 1 | 24 | ||
16,67% | 66,67% | 4,17% | 0,00% | 8,33% | 4,17% | 100,00% | |||
FEMMES | 0 | 10 | 0 | 2 | 0 | 1 | 13 | ||
0,00% | 76,92% | 0,00% | 15,38% | 0,00% | 7,69% | 100,00% | |||
TOTAL | 4 | 26 | 1 | 2 | 2 | 2 | 37 | ||
10,81% | 70,27% | 2,70% | 5,41% | 5,41% | 5,41% | 100,00% | |||
|
|||||||||
|
|||||||||